Harmatz, Jerold S.

Sensitivity to triazolam in the elderly

Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine

Pharmaceutical Practices and Patient OutcomesAnesthesia and Sedative Agents

Cited by 258

Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans

Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E. (1979) · Journal of Pharmaceutical Sciences

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 197

Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam

Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982) · Journal of Pharmaceutical Sciences

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 134

Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration

Greenblatt, D. J., Harmatz, J. S., Singh, N. N., Steinberg, F., Roth, T., Moline, M. L., Harris, S. C., & Kapil, R. P. (2014) · The Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 107

Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men

Olubodun, J. O., Ochs, H. R., Von Moltke, L. L., Roubenoff, R., Hesse, L. M., Harmatz, J. S., Shader, R. I., & Greenblatt, D. J. (2003) · British Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 104

Implications of Altered Drug Disposition in the Elderly: Studies of Benzodiazepines

Greenblatt, D. J., Shader, R. I., & Harmatz, J. S. (1989) · The Journal of Clinical Pharmacology

Pharmaceutical Practices and Patient OutcomesPharmacogenetics and Drug Metabolism

Cited by 102

Effect of Gradual Withdrawal on the Rebound Sleep Disorder after Discontinuation of Triazolam

Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., & Shader, R. I. (1987) · New England Journal of Medicine

Sleep and related disordersSubstance Abuse Treatment and Outcomes

Cited by 96

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

GREENBLATT, D., HARMATZ, J., VONMOLTKE, L., WRIGHT, C., & SHADER, R. (2004) · Clinical Pharmacology & Therapeutics

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 93

Desmethyldiazepam pharmacokinetics: studies following intravenous and oral desmethyldiazepam, oral clorazepate, and intravenous diazepam

Greenblatt, D. J., Divoll, M. K., Soong, M. H., Boxenbaum, H. G., Harmatz, J. S., & Shader, R. I. (1988) · The Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismAnesthesia and Sedative Agents

Cited by 42

Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution Test

Greenblatt, D. J., Gan, L., Harmatz, J. S., & Shader, R. I. (2005) · British Journal of Clinical Pharmacology

Anesthesia and Sedative AgentsPharmacogenetics and Drug Metabolism

Cited by 33